|
Real-time Estimate
Cboe BZX
15:54:50 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 80.64 USD | +3.00% |
|
+1.56% | +24.42% |
| 10-05 | Monopar Therapeutics Insider Sold Shares Worth $659,387, According to a Recent SEC Filing | MT |
| 09-20 | Monopar Therapeutics Inc.(NasdaqCM:MNPR) added to S&P Biotechnology Select Industry Index | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.00% | +1.56% | -28.97% | -16.35% | +24.42% | -18.35% | +2,806.80% | +257.12% | - | 525M | |
| +4.16% | +3.42% | +8.78% | +34.82% | +84.62% | +49.37% | +94.17% | +9.52% | - | 74.31B | |
| +2.76% | -1.60% | -3.98% | +2.68% | +16.46% | +22.80% | +78.53% | +228.53% | +5,432.14% | 56.95B | |
| +0.24% | -1.34% | +2.78% | -0.72% | +7.14% | +3.41% | +34.31% | -17.64% | +209.45% | 48.3B | |
| -3.88% | -2.86% | -4.19% | +4.54% | +149.37% | +326.42% | +693.23% | +617.84% | - | 44.51B | |
| -2.31% | -3.07% | +0.59% | +26.59% | +15.67% | +27.18% | +31.26% | +8.91% | +228.93% | 43.8B | |
| +0.31% | -0.85% | +3.04% | +17.03% | +19.20% | +5.12% | +108.28% | +6.83% | +1,039.21% | 41.12B | |
| -0.11% | +2.30% | -3.03% | -0.65% | +5.81% | +9.19% | +58.68% | +1.77% | +144.64% | 31.07B | |
| +4.51% | +8.43% | +17.73% | +54.15% | +84.16% | +37.27% | +34.97% | -50.85% | - | 28.97B | |
| -1.90% | -3.00% | -3.09% | +1.79% | +0.44% | -9.08% | -14.02% | -59.51% | - | 24.53B | |
| +1.27% | -9.58% | -16.29% | -6.27% | -39.93% | -33.95% | +327.78% | +280.74% | +618.56% | 22.67B | |
| +4.42% | +7.12% | +15.93% | +35.81% | +22.45% | +17.13% | -0.28% | -10.88% | +118.49% | 21.31B | |
| -3.85% | -3.07% | +2.05% | +6.71% | +7.36% | +13.71% | +145.04% | +213.25% | +1,951.74% | 17.32B | |
| -1.26% | +1.73% | -10.31% | -6.57% | +177.32% | +133.17% | +345.74% | +1,714.84% | +655.31% | 15.53B | |
| -0.88% | +0.40% | -15.22% | -14.53% | - | - | - | - | - | 14.98B | |
| +0.79% | -0.08% | +6.34% | +10.83% | +22.02% | +22.53% | +43.82% | -29.15% | +85.21% | 14.7B | |
| -0.93% | -1.29% | +0.39% | +4.26% | +32.09% | +44.70% | +160.55% | +177.01% | +339.26% | 14.58B | |
| +1.75% | +5.01% | -2.33% | -4.21% | +21.88% | -14.87% | +512.82% | - | - | 14.31B | |
| -1.77% | +2.46% | +8.01% | +31.04% | +52.02% | +73.34% | +56.75% | -25.64% | +264.05% | 14.84B | |
| -13.27% | -12.76% | +12.05% | +18.68% | +22.00% | -22.60% | - | - | - | 15.08B | |
| Average | -0.37% | -0.83% | -0.49% | +9.98% | +38.13% | +36.13% | +306.58% | +195.45% | +923.92% | 27.97B | |
| Weighted average by Cap. | +0.16% | -0.71% | +1.50% | +13.72% | +42.25% | +47.05% | +151.60% | +148.60% | +1,307.38% |
- Stock Market
- Stocks
- MNPR Stock
- Sector Monopar Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
